Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Maintaining Neutral Rating with Raised Price Target for SM Energy

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Renewable-energy
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Susquehanna analyst Biju Perincheril has decided to maintain a Neutral rating on SM Energy (NYSE:SM) on February 26, 2024. However, he has raised the price target from $38 to $42, showing a more optimistic view on the stock’s potential performance. This adjustment suggests that Perincheril sees some positive developments ahead for SM Energy.

SM Stock Performance Update: Slight Decrease on February 26, 2024, but Still Strong Compared to Historical Performance

On February 26, 2024, SM stocks showed a slight decrease in performance, with the price dropping by $0.04 since the last market close. This represents a 0.10% decrease in value. The stock opened at $41.23, which was $0.19 lower than its previous close. Despite this slight dip in performance, SM is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time, and investors may still have confidence in its potential for growth. It is important for investors to closely monitor the performance of SM stocks in the coming days to see if this slight decrease is a temporary fluctuation or the start of a larger trend. Keeping an eye on market trends and news related to the company can help investors make informed decisions about buying, selling, or holding onto their SM stocks. Overall, while there was a slight decrease in SM stock performance on February 26, 2024, the stock is still showing strength compared to its historical performance. Investors should continue to stay informed and monitor the stock closely to make the best decisions for their investment portfolios.

SM Stock Performance Analysis: Revenue and Net Income Decline in 2024

On February 26, 2024, investors were closely watching the performance of SM stock after the company released its latest financial results. SM reported total revenue of $2.37 billion for the past year, a decrease of 29.32% compared to the previous year. Total revenue remained flat compared to the previous quarter, coming in at $608.73 million for Q4.

SM’s net income for the past year was reported at $817.88 million, showing a decrease of 26.45% from the previous year. Net income also held flat compared to the previous quarter, with Q4 net income coming in at $247.11 million.

Earnings per share (EPS) for SM were reported at $6.86 for the past year, representing a 23.46% decrease from the previous year. EPS remained unchanged compared to the previous quarter, with Q4 EPS reported at $2.12.

Overall, SM’s financial performance showed a decline in key metrics compared to the previous year. However, the company was able to maintain stability in its financial performance compared to the previous quarter. Investors will be monitoring future developments and announcements from SM to assess the company’s growth prospects and potential for improvement in financial performance.

Tags: SM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Enlivex Receives Regulatory Approval for Phase 12 Clinical Study on Allocetra for Knee Osteoarthritis

Finance_Fiscal (3)

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

Biotechnology Stock Market Today (1)

Owlet Announces 9 Million Private Placement Financing Deal with Series B Preferred Stock

Recommended

Red Cat Stock

Red Cat Shares Face Turbulence After Stellar Rally

4 months ago

PHX Minerals Exceeds Q1 Earnings Expectations Despite Revenue Decline

2 years ago
Elanco Animal Health Stock

Indianapolis Emerges as Animal Health Innovation Hub Through Elanco’s Strategic Move

5 months ago
Home Construction Stock Exchange

Analyzing Southland Holdings Q4 Earnings Performance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

NCR Voyix Charts a Course Toward Cloud-Centric Growth

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

Trending

iRobot Stock
Mergers & Acquisitions

iRobot Exits Public Markets Following Bankruptcy and Acquisition

by Dieter Jaworski
February 5, 2026
0

The restructuring of iRobot under Chapter 11 bankruptcy protection has concluded, resulting in the company's delisting from...

Exxon Mobil Stock

Exxon Mobil Charts a New Course with Major Carbon Capture Initiative

February 5, 2026
CrowdStrike Stock

CrowdStrike Shares Face Headwinds Amid Mixed Signals

February 5, 2026
NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • iRobot Exits Public Markets Following Bankruptcy and Acquisition
  • Exxon Mobil Charts a New Course with Major Carbon Capture Initiative
  • CrowdStrike Shares Face Headwinds Amid Mixed Signals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com